SEC Form 5 · accession 0001203311-15-000004
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clay B Siegall
Officer — President and CEO · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 13, 2015 · 3:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 25, 2014 | G | 2,688 | $0.00 | D | 557,022 | D | |
| Common Stock | holding | — | — | — | 100,000 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Amount of securities beneficially owned includes Restricted Stock Units subject to vesting.